Boston Scientific Corporation (BSX)
NYSE
Real-time Data
01:30 PM
Day's Range
48.7752 wk Range
42.20Overview - BSX - Boston Scientific Corporation
Key Statistics
Valuation
Enterprise Value
85.32B
P/E (Trailing)
‪20.39‬
P/E (Forward)
‪14.67‬
PEG Ratio
‪1.37‬
Price / Sales (TTM)
‪3.47‬
Price / Book
‪2.92‬
EV / EBITDA
‪14.94‬
Profitability
Gross Margin
‪70.70%‬
Profit Margin
‪17.49%‬
Operating Margin
‪22.89%‬
Return on Assets
‪6.19%‬
Return on Equity
‪15.33%‬
Ownership
Shares Outstanding
1.44B
Float
1.44B
Short % of Shares Outstanding
‪1.54%‬
Held by Insiders
‪0.25%‬
Held by Institutions
‪95.36%‬
Price stats
Beta
‪0.56‬
50-Day Avg
‪46.42‬
200-Day Avg
‪69.43‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
31 analysts
Average price target
‪$ 62.69‬Shariah Compliance
Report Date: Feb 17, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - BSX - Boston Scientific Corporation
Peers - BSX - Boston Scientific Corporation
Peer Comparison
Compared with companies in Medical Devices listed on NYSE.
Profile Summary - BSX - Boston Scientific Corporation
About
Boston Scientific Corporation develops, manufactures, and markets a broad portfolio of medical devices designed for minimally invasive procedures worldwide. The company specializes in innovative technologies that address critical health needs across cardiology, endoscopy, and neuromodulation. Its Cardiovascular…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
